| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3476(98)70303-8 |
| P698 | PubMed publication ID | 9602185 |
| P2093 | author name string | Lior H | |
| Rowe PC | |||
| McLaine PN | |||
| Orrbine E | |||
| Wells GA | |||
| Clulow M | |||
| Yetisir E | |||
| P2860 | cites work | Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome | Q33371235 |
| The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic Syndrome | Q33375970 | ||
| Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre | Q33380264 | ||
| High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome | Q33381234 | ||
| Haemolytic anaemia after childhood Escherichia coli O 157 .H7 infection: are females at increased risk? | Q33389799 | ||
| Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations | Q33396501 | ||
| Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology | Q33397493 | ||
| Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes | Q33397981 | ||
| Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins | Q33428528 | ||
| Further evidence associating hemolytic uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7. | Q33453243 | ||
| Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center | Q33453248 | ||
| The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli | Q33457864 | ||
| Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools | Q33475757 | ||
| The hemolytic-uremic syndrome: spectrum of severity and significance of prodrome | Q33476523 | ||
| Incomplete hemolytic-uremic syndrome in Argentinean children with bloody diarrhea | Q33489027 | ||
| A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience | Q33490973 | ||
| Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli | Q33493367 | ||
| Epidemic Escherichia coli O157:H7 gastroenteritis and hemolytic-uremic syndrome in a Canadian inuit community: intestinal illness in family members as a risk factor | Q33493394 | ||
| Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities | Q33494265 | ||
| A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators | Q33494314 | ||
| Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91 | Q33494928 | ||
| Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis | Q40205809 | ||
| Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. | Q50557922 | ||
| Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. | Q54748961 | ||
| An Outbreak of Escherichia coli 0157:H7 Colitis Associated with Consumption of Precooked Meat Patties | Q64128340 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| collaboration | Q1145523 | ||
| kidney disease | Q1054718 | ||
| P304 | page(s) | 777-782 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center | |
| P478 | volume | 132 |
| Q33383011 | An outbreak of diarrhea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic |
| Q33412570 | Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae |
| Q33358459 | Current status of kidney transplant: update 2003. |
| Q33287522 | Epidemiological characteristics of reported sporadic and outbreak cases of E. coli O157 in people from Alberta, Canada (2000-2002): methodological challenges of comparing clustered to unclustered data |
| Q26801344 | Escherichia coli O157 Outbreaks in the United States, 2003-2012 |
| Q56765607 | Escherichia coli O157:H7 as an emerging foodborne pathogen: a literature review |
| Q34391524 | Escherichia coli O157:H7. |
| Q74591007 | Escherichia coli O157:H7: assessing and minimizing the risk from farm to fork |
| Q33383008 | Experiences with HUS in Canada: what have we learned about childhood HUS in Canada? |
| Q74183498 | Haemolytic uraemic syndrome |
| Q42761163 | Haemolytic uraemic syndrome and E coli O157 |
| Q33371444 | Haemolytic uraemic syndrome: an overview |
| Q54624230 | Hemolytic uremic syndrome related to cryptosporidium infection in an immunocompetent child. |
| Q33559388 | Hemolytic uremic syndrome: Events of the past decade |
| Q33598843 | Human response to Escherichia coli O157:H7 infection: antibodies to secreted virulence factors |
| Q94354233 | Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome |
| Q48352239 | Management of Shiga toxin producing Escherichia coli-infected children: A multi-national, multi-specialty survey |
| Q27002576 | Management of hemolytic-uremic syndrome in children |
| Q33328791 | Neuropsychological sequelae of haemolytic uraemic syndrome. Investigators of the HUS Cognitive Study |
| Q37435390 | Non-O157:H7 Shiga Toxin Producing Diarrhoeagenic Escherichia coli (STEC) in Southern India: A Tinderbox for Starting Epidemic |
| Q33966924 | Performance of the ImmunoCard STAT! E. coli O157:H7 test for detection of Escherichia coli O157:H7 in stools |
| Q47716348 | Prevalence of Escherichia coli O157:H7 and Salmonella spp. in surface waters of southern Alberta and its relation to manure sources |
| Q33365868 | Prospective surveillance of Canadian children with the haemolytic uraemic syndrome |
| Q34006082 | Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits |
| Q24652310 | Shiga toxin 2 targets the murine renal collecting duct epithelium |
| Q35003696 | Shiga toxin 2-induced endoplasmic reticulum stress is minimized by activated protein C but does not correlate with lethal kidney injury. |
| Q34298167 | Shiga toxin-producing Escherichia coli: a single-center, 11-year pediatric experience. |
| Q92465398 | Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study |
| Q33379319 | Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison |
| Q40095881 | Strand-specific transcriptomes of Enterohemorrhagic Escherichia coli in response to interactions with ground beef microbiota: interactions between microorganisms in raw meat. |
| Q43742260 | Survival of Escherichia coli O157:H7 on strawberry fruit and reduction of the pathogen population by chemical agents |
| Q24623245 | The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections |
| Q33504456 | Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management |
| Q33380757 | Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). |
| Q38588986 | Verotoxigenic Escherichia coli transmission in Ireland: a review of notified outbreaks, 2004-2012. |
| Q46175956 | Yogurt containing bioactive molecules produced by Lactobacillus acidophilus La-5 exerts a protective effect against enterohemorrhagic Escherichia coli in mice |
Search more.